Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature
Sign Up to like & getrecommendations! Published in 2020 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12677
Abstract: In the coming decade, heart failure (HF) represents a major global healthcare challenge due to an ageing population and rising prevalence combined with scarcity of medical resources and increasing healthcare costs. A transitional care strategy… read more here.
Keywords: intravenous subcutaneous; heart; treatment worsening; outpatient treatment ... See more keywords
Pharmacokinetics of intravenous, subcutaneous, and topical administration of lidocaine hydrochloride and metabolites 3‐hydroxylidocaine, monoethylglycinexylidide, and 4‐hydroxylidocaine in horse
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Veterinary Pharmacology and Therapeutics"
DOI: 10.1111/jvp.12695
Abstract: Intravenous (iv), subcutaneous (sq), and topical (tp) lidocaine was administered to six horses in a cross-over, randomized design study. Samples were collected for up to 72 hr. Compartmental models were used to investigate the pharmacokinetics of… read more here.
Keywords: intravenous subcutaneous; administration; median range; subcutaneous topical ... See more keywords
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Open Gastroenterology"
DOI: 10.1136/bmjgast-2023-001105
Abstract: Background We aim to compare the real-life direct and indirect costs of switching patients from intravenous to subcutaneous (SC) CT-P13, an infliximab biosimilar, in a tertiary UK Inflammatory Bowel Disease (IBD) centre. Methods All adult… read more here.
Keywords: intravenous subcutaneous; switching patients; cost; costs switching ... See more keywords
The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacology"
DOI: 10.1159/000527655
Abstract: Background: Intravenous immunoglobulin and subcutaneous immunoglobulin preparations are used to treat primary and secondary immunodeficiencies, as well as autoimmune and inflammatory conditions. Summary: For certain indications, only defined formulations or routes of administration are approved… read more here.
Keywords: intravenous subcutaneous; pharmacology; aspects consideration; subcutaneous immunoglobulins ... See more keywords
Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0261336
Abstract: Subcutaneous (SC) administration of rituximab provides an opportunity for reduced patient treatment burden and increased healthcare efficiencies as an alternative to intravenous (IV) rituximab. There is minimal evidence comparing costs associated with SC and IV… read more here.
Keywords: health; transition intravenous; intravenous subcutaneous; assessing transition ... See more keywords
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1063144
Abstract: Daratumumab is a CD38-directed monoclonal antibody indicated to treat multiple myeloma (MM). Daratumumab was initially administered intravenously (IV), subsequently a subcutaneous (SC) formulation was developed to increase convenience of administration. The UK was an early… read more here.
Keywords: benefits switching; healthcare providers; daratumumab; intravenous subcutaneous ... See more keywords
Pharmacokinetics of esomeprazole in goats (Capra aegagrus hircus) after intravenous and subcutaneous administration
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Veterinary Science"
DOI: 10.3389/fvets.2022.968973
Abstract: Background Stressed and hospitalized goats are at risk of developing abomasal (gastric) ulceration, but there is a paucity of pharmacokinetic studies for proton pump inhibiting drugs, such as, esomeprazole in goats. Objectives The objectives for… read more here.
Keywords: administration; esomeprazole goats; intravenous subcutaneous; half life ... See more keywords
Toxicity, Safety, and Efficacy Studies on Mesenchymal Stem Cells Derived from Decidua basalis in Wistar Albino Rats by Intravenous and Subcutaneous Routes
Sign Up to like & getrecommendations! Published in 2022 at "Current Issues in Molecular Biology"
DOI: 10.3390/cimb44090277
Abstract: Ex vivo expanded decidua-basalis(DB)-derived mesenchymal stem cells (MSCs) obtained from single donors have demonstrated therapeutic benefits in in vitro and in vivo studies. In this report, the intravenous and subcutaneous administration of DB-MSCs obtained from… read more here.
Keywords: intravenous subcutaneous; wistar albino; albino rats; mesenchymal stem ... See more keywords